LEADER 01355nam  2200313z- 450 
001 9910694076203321
005 20060612111753.0
035   $a(CKB)5600000000079885
035   $a(BIP)013643675
035   $a(EXLCZ)995600000000079885
100   $a20211123c2004uuuu  -u-         -
101 0 $aeng
200 10$aFlu vaccine $eprotecting high-risk individuals and strengthening the market : joint hearing before the Subcommittee on Health and the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, second session, November 18, 2004
215   $a1 online resource (v, 122 p.) 
311   $a0-16-075391-0 
517   $aFlu Vaccine
606   $aInfluenza vaccines$zUnited States$xInventories
606   $aVaccines industry$zUnited States$xInventories
610   $aInfluenza
610   $aVaccines
610   $aMedical
615  0$aInfluenza vaccines$xInventories.
615  0$aVaccines industry$xInventories.
712 02$aUnited States, Congress House Committee on Energy and Commerce Subcommittee on Health Staff,$4oth
712 02$aUnited States, Congress House Committee on Energy and Commerce Subcommittee on Oversight and Investigations Staff,$4oth
906   $aBOOK
912   $a9910694076203321
996   $aFlu vaccine$93113305
997   $aUNINA